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Abstract
Novartis Vaccines and Diagnostics has made a strong commitment to manufacturing
seasonal influenza vaccines through their cell culture technology called Optafluo. The goal of
this project is to improve overall process yield by modifying the upstream process. The focus is
on using a batch process to generate a high-density cell culture and then infecting said culture.
This thesis presents the approach of using a Design of Experiment series to change a
manufacturing process.
Current vaccine production occurs with a fed-batch process by feeding glucose as a
carbon-energy source for the final cell expansion step. This cell culture is diluted, infected,
harvested, and purified for use in an influenza vaccine. Primarily, the project aims to increase
cell density, using a batch process, at the infection step which should improve overall process
yield. The project can therefore be broken into two main steps: batch cell growth and high-
density infection.
Experiments for this project were conducted with a small-scale laboratory process that
mimics the production process. The planned approach was a Design of Experiment series to
screen parameters and partially optimize the cell growth process, a scale-up cell growth
experiment, and finally another Design of Experiment series to explore high-density cell
infection. While initial small-scale experiments showed extremely positive results, the results
were not consistent and could not be replicated at a larger scale. A number of exploratory
experiments were run to attempt to identify which factors inhibit high-density cell growth,
particularly around scale-up, but no key parameter was identified. Given the process
improvement and cost savings implications from the success of the initial small-scale
experiments, this project is worth further exploration.
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Chapter 1: Introduction
This thesis covers the research conducted during a six month internship within the V&D
division of Novartis AG between June and December of 2009. This project was sponsored by the
Vaccine division's Technology Development group and the objective was to evaluate the
feasibility of infecting high-density cell cultures made from a batch procedure. Included in this
thesis is a series of experiments to test the feasibility of batch cell growth for high-density cell
infection and an analysis of the experiment results.
1.1 Problem Statement
Novartis V&D has made a strong commitment to manufacturing seasonal influenza
vaccines through cell culture technology. FCC technology has a number of advantages over
traditional egg-based vaccines but the overall process is new, relative to the egg-based vaccine
process, and still has a number of optimization and robustness challenges to overcome. This
thesis focuses on the challenge of growing cells with a batch process to generate a high-density
cell culture for infection with an influenza virus strain.
1.2 Approach
To generate the high-density cell culture necessary for infection, a simple design of
experiment is used to screen important factors and then to optimize the batch process at a small
scale within the laboratory. Discussions with a number of company personnel, along with a
literature review of animal cell cultures, generated the list of factors to screen with the initial
and then follow-up experiments. After initial experimental data was collected an analysis was
performed to determine and model the effects and interactions of the various parameters. This
model indicated the optimal conditions to maximize cell production and was used as a starting
point for additional optimization at a larger laboratory scale.
Once this small scale data was collected and the most promising settings determined, the
experiment was repeated at a larger laboratory scale so that the infection step could occur and
data from the downstream processes could be collected. When the scale-up process failed to
produce positive results the project focus shifted to an exploration of factors influencing scale-
up. While the overall goal of the project was to improve the primary yield of the downstream
process, experimental results in the upstream process dictated that the research instead focus
solely on batch cell growth.
1.3 Organization of the Thesis
Chapter One introduces the problem and briefly discusses the approach taken in this thesis to
resolve the problem.
Chapter Two gives a background on Novartis, the V&D division, and the influenza vaccine
industry.
Chapter Three describes the overall process of making flu vaccines using FCC technology and
further details the process details related to this project.
Chapter Four describes the materials, equipment, and lab procedures used to conduct the
experiments for this thesis.
Chapter Five covers the approach, data collected, and results of the experiments used to develop
this thesis.
Chapter Six concludes the thesis and makes recommendations for future research to build on
this thesis.
Chapter 2: Background
Chapter 2 gives a brief introduction to the internship host company Novartis and the influenza
vaccine industry. This information provides some context before exploring the subject matter of
the thesis.
2.1 Novartis and the Vaccines and Diagnostics Division
Novartis is a multinational pharmaceutical company that was created with the merger of
Ciba-Geigy and Sandoz in 1996. Based in Basel Switzerland, Novartis is one of the largest
health care companies ranking 3rd in sales of pharmaceutical companies in 2008 with $36.172
billion in sales . Novartis divides their business into four sectors called Pharmaceuticals,
Vaccines and Diagnostics, Consumer Health, and Sandoz which is their generics division2.
Vaccines and Diagnostics, where this internship takes place, is the newest Novartis division and
it was formed after Novartis acquired Chiron Corporation in 20063. Novartis Vaccines and
Diagnostics can be further broken down into Novartis Vaccines and Chiron blood testing which
focuses on blood screening testing 4. The Novartis Vaccines portfolio includes vaccinations
against Influenza, Meningitis, Rabies, Japanese encephalitis, Tick-borne encephalitis,
Haemophilus Influenzae type B (Hib), Polio, Diphtheria, Tetanus, and Pertussis (whooping
cough) 5.
2.2 Influenza Vaccine General Information and Industry Background
An influenza, or flu, vaccine is used to deliver the main proteins of a particular flu virus
strain into a person. Once a body receives these proteins it can create the antigens necessary to
prevent the spread of that viral strain in the event that infection occurs. One of the main
challenges of the influenza vaccine industry is the number of influenza strains in existence and
how quickly these strains evolve.
While there are a great number of different influenza strains, the yearly flu vaccine is
designed to protect against only three different subtypes of the virus. Typically, the vaccine
protects against two strains from the Influenza A family and one from the Influenza B family.
Influenza viral strains evolve so quickly that the vaccine from any given year rarely protects
against the same strain as the previous year. The situation is further complicated by the division
of the population into Northern and Southern hemispheres which have winter at different times
of the year and thus have different peak flu seasons and typically different dominant viral
strains.
Strains in the yearly influenza vaccine are determined by the WHO as they collect data
throughout the world and try to predict the strains that will be most prevalent in the upcoming
flu season. The WHO works with a number of regional centers to collect influenza data and
then works with vaccine manufacturers, who are constantly screening new strains with their
manufacturing process, to select the strains for the upcoming flu season. Official strain
selection information is released annually by the WHO for both the Northern and Southern
hemisphere approximately 10 months before the flu season of that hemisphere begins. For the
Northern Hemisphere, strain selection information is released between January and March and
finished product must be available as soon as October. This short time period provides vaccine
manufacturers with less than seven months to optimize their manufacturing process for the new
strains and then to fully ramp up production. Many companies, Novartis included, will track
and trend the popular virus strains along with the WHO, estimate the dominant strains before
the WHO releases the final selection, and then begin production in an attempt to beat
competition to market. This risk does not always pay off as product with incorrect strains must
be discarded.
Chapter 2 introduced the company and industry to which the thesis pertains. The upcoming
chapter will further explore the relevant process details pertaining to the thesis.
Chapter 3: Overview of Flu Cell Culture Process
Chapter 3 provides the background necessary to understand the overall FCC production process
and some of the challenges that led to the use of batch experiments over fed-batch for high cell
density infection.
3.1 Novartis Influenza Vaccine Production Process Overview
For Novartis to create a vaccine against a particular viral strain, that viral strain has to be
grown, harvested, and then deactivated and purified so that the desired proteins from that virus
can be injected into a patient. The two methods used to generate the large quantities of infected
material are infection of embryonic chicken eggs and infection of animal cells that are grown in
a bioreactor. While the two methods differ in their creation of infected materials, once this
material is harvested the processes is similar.
Since the development of a working influenza vaccine in the 1940s, the traditional method
of producing infected material for harvesting is with embryonic chicken eggs6 . While egg-
based production is a successful and proven process it has a number of challenges. One such
challenge is the lack of flexibility in the sourcing of eggs and the supply chain for the process.
Approximately one embryonic egg is required to produce one tri-strain vaccine and embryonic
eggs require over six months of lead time7 . This inflexibility prevents the process from
accommodating deviations such as production failures, viral strain changes, or
uncharacteristically high demand such as with a pandemic situation 8. Embryonic eggs are also
at risk of infection from viruses such as avian flu, which could decimate the raw material supply
well after steps could be taken to replace the supply. Finally, persons allergic to eggs may have
reactions to egg-based vaccines.
Challenges with the egg-based process led Novartis to research and develop a method of
creating infected viral material using animal cell culture as the host. FCC research began in
1985 and reached small scale fermenter manufacturing runs by 19929. Phase I and II clinical
trial material was made in 2002 and phase III in 2004 and 2005. The Novartis FCC vaccine
has been released under the name Optaflu@ and approval from the European Union was granted
in 2007".
The cell culture process can be broken into upstream and downstream processes. The
upstream process is diagramed in Figure 1: Downstream Process Overview and includes Steps
- - - -i*- __ - - - - ___ -- I~ I ----
(1) seed-source cell expansion in multiple lab spinner flasks, (2) further cell expansion in
consecutively larger bioreactors, (3) high-density cell expansion with a fed-batch process, (4)
viral infection, (5) virus propagation as the virus spreads among the cells, (6) centrifugation to
remove cells and debris, and (7) filtration to remove additional contaminants.
Glucose
iVirus
o  Propagation
3 o Centrifugation
- - Filtration
Figure 1: Downstream Process Overview
After filtration in the upstream process the product flows through a series of downstream
processes which include virus inactivation, splitting and sub-unit extraction, and polishing
purification. While the details of the downstream process are not relevant to this thesis the
main function of the downstream process is to isolate the desired antigens and remove as many
contaminants as possible so that the product is fit for injection in human patients.
3.2 Cell Growth Details
Overall, the laboratory processes used for experimenting are similar to the scaled up
manufacturing process. For both processes the cells are expanded by adding a small solution
containing cells to a growth media containing essential material for biological growth. Initially
this cell expansion occurs in small incubated flasks, Step (1) of Figure 1: Downstream Process
Overview, with only temperature and headspace CO 2 controls. Next, the growth and then
infection occurs in closed bioreactors with a number of additional process controls such as PO2,
glucose feed rate, and pH, Steps (2) - (5). In the laboratory these bioreactors are between one
and eight liters and in the manufacturing process the bioreactors can be as large as 5,000 liters.
All cell expansion steps except for the last stage typically increase the cell culture density by a
factor of 10 at which point the solution is transferred to a larger vessel and diluted in growth
media to the starting cell density for further expansion. The final high-density cell expansion,
Step (3), typically increases the cell culture density by a factor of 30. The need to dilute the
culture to the starting cell density at the end of each cell growth stage significantly increases the
overall culture volume of the process, from one liter to 5,000 liters, and has a significant impact
on the size of equipment in the manufacturing process.
3.3 Fed-Batch Process and Possible Batch Process
To achieve the high cell densities of the last expansion step, Step (3), the current process
uses a fed-batch system. In a batch process all of the ingredients are added at the start of the
reaction. Fed-batch implies that some ingredients are fed, as the reaction occurs, to what would
otherwise be a batch process. For this process the only fed ingredient is glucose which serves
as a food source for the cells. Glucose additional rates are determined by the number of cells
currently in the bioreactor, so the glucose addition rate increases as cell growth occurs and
varies depending on how efficiently the reaction is occurring.
Replacing the fed-batch step with a batch step is a simple change in this process. All of
the glucose would be added to the growth media and cell solution at the beginning of the final
cell expansion step. After that, the cell growth would continue until the high-density
concentration level is achieved. A batch process has the benefit of simplicity compared to a
fed-batch process. In the fed-batch process, glucose must be adjusted daily depending on the
current cell concentration. This action introduces variability in the process and makes the
manufacturing process difficult to schedule and manage. A batch process requires no daily
measurement of cell count and no adjustment of the glucose feed rate and thus has a lower
chance for variability compared to the fed-batch system.
The current manufacturing process is verified up to a cell density level that can be
consistently reached with a fed-batch process. If another process for growing cells, such as a
batch system, can consistently reach a higher cell density it would allow for a larger number of
infected cells in the final bioreactor with the same dilution ratio. As will be detailed in the
High-Density Cell Infection section, a higher cell density at infection may lead to an
improvement in overall yield.
3.4 High-Density Infection
Through past studies performed by Novartis it is known that final product yield increases
as infection cell density increases, as seen in Figure 2: Infection Cell Density versus SRD Yield.
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Figure 2: Infection Cell Density versus SRD Yield1
For the research referenced in Figure 2: Infection Cell Density versus SRD Yield, cultures
with a higher cell density than the standard cell density were generated through a perfusion
process. A perfusion process involves feeding fresh media into a culture while withdrawing an
equal volume of spent media. While this method was able to generate cultures that are ten
times as dense as the standard culture with a final yield that was three times greater, the
economics of continuously feeding fresh media did not make this a feasible production process.
In the standard fed-batch process, the contents of the cell growth bioreactor are transferred
to a larger bioreactor containing a different media than the one used during cell growth. As
shown in Figure 1: Downstream Process Overview Step (4), infection occurs in a bioreactor that
is larger than the bioreactor used to grow the cells and a different media is used for infection
than the media used for cell growth. It should be noted that the perfusion process used for
Figure 2: Infection Cell Density versus SRD Yield, which exchanges old media for new media,
could have removed contaminants and would therefore be misleading on the effectiveness of
high density infection.
This chapter has outlined the overall FCC production process and then given detail relevant to
this thesis for cell growth through a batch or a fed-batch process. The chapter concludes with a
discussion of the historical data that led to this thesis and why it is believed that batch system will
be successful. As stated in this chapter, the purpose of this thesis is to test if batch grown cells
follow the trend in Figure 2: Infection Cell Density versus SRD Yield where a higher cell density
leads to a higher overall process yield. In the next chapter we will review the material,
equipment, and methods used in this thesis before explaining the approach taken for this project
in the following chapter.
Chapter 4: Material, Equipment, and Methods
This chapter covers the different laboratory materials, equipment, and methods used to conduct
the experiments outlined in this thesis.
4.1 Material
4.1.1 Cells
The Novartis FCC process has been developed with MDCK epithelial cells as the
host cells for infection. The MDCK cell line was initiated in 1958 by S. H. Madin and N. B.
Darby from the kidney tissue of an adult female cocker spaniel13. The MDCK line is
susceptible to a number of viruses besides the influenza virus which makes it a popular tool
for study14 . Novartis maintains their own particular MDCK cell line called MDCK 33016 in
an internal working cell bank to preserve the integrity of the cell line.
4.1.2 Chemical Defined Media
During the various cell growth stages, a small quantity of cell culture is added to a
large quantity of media at a set ratio to meet a targeted cell density. This media provides the
ingredients and the overall dilution necessary for cell growth.
4.1.3 Other Cell Culture Growth Additives
Concentrated solutions of Amino Acids, Vitamins, Trace Metals, Glucose, etc. were
used to vary individual parameters for designed experiments. A list of the different
chemicals used during any experiment and any pertinent information about said chemicals
can be found in Appendix 1: Raw Material Information.
4.2 Equipment
4.2.1 Bioreactor
For these experiments the bioreactors used were one liter glass vessels with a culture
volume of 1.1 liters. The controls for the bioreactor were managed with a BIOSTAT Q
system that controls headspace gas flow and content, P0 2, pH, temperature, and stir speed.
Temperature is maintained by pumping hot or cold water through the insulation system
surrounding the bioreactor and stir speed is controlled through a top-loaded variable speed
motor that rotates a central shaft. The stirring device is a single pitched blade impeller with
down-pumping agitation. To control both pH and P0 2 the system manages a constant flow
of headspace gas at a controlled ratio of air, C0 2, and nitrogen. Further control of p02 is
through a sparger that delivers oxygen gas to the bottom of the vessel and further pH control
is by the addition of a sodium hydroxide solution to the culture.
4.2.2 Glass Vessel
The 100 milliliter, one liter, and two liter vessel are sterilized glass vessels of
cylindrical shape with sealable lids used to simulate a bioreactor. To allow for air exchange
during cell growth, the caps are loosened but not removed from the vessel once placed in the
incubator according to currently used lab policy.
4.2.3 Incubator
The incubator used for the shaker flasks experiments was a Heraeus 6000. The
incubator is certified for and was maintained at the targeted temperature ± 10C and at the
targeted % CO 2 ± 1% CO 2.
4.2.4 Shaker Flask
Disposable plastic shaker flasks are used as a small-scale simulation of bioreactors.
The polycarbonate erlenmeyer/shaker culture flasks were 250 mL flasks equipped with a
DuoCAP which allows for sterile air exchange. A glass shaker flask with a sealable plastic
lid was also used to explore the impact of vessel material. To allow for air exchange during
cell growth, the caps are loosened but not removed from the vessel once placed in the
incubator according to currently used lab policy
4.2.5 Shaker Plate
A Sartorius Certomat MOII shaker plate inside the incubator provided rotational
agitation for the shaker flasks. While the shaker plate is capable of various speeds the plate
agitation remained constant for all experiments.
4.3 Methods
A list of the standard information collected for the experiments conducted in this thesis can be found in
Appendix 2: Experiment Test Information. Further pertinent information about the
methods used is listed below.
4.3.1 Cell Count and Viability
To determine the cell density of viable cells in a solution the Beckman Coulter Vi-
cell XR viability analyzer was used. This vi-cell measuring device has been verified within
the Novartis laboratory and is their standard method of cell density measurement.
4.3.2 Nova Analyzer
To measure the concentration of glucose, glutamine, glutamic acid, lactate, ammonia
ion, and the osmolality a Nova Biomedical 100 Plus Bioprofile Analyzer was used.
4.3.3 PHOX Analyzer
To measure the dissolved 02 and CO 2 a Nova Biomedical Bioprofile PHOX was
used.
4.3.4 Sterile Handling and Sampling Techniques
For initial cell expansion and spinner flask work cells, and other components, were
transferred within a laminar flow hood using sterile lab equipment. Daily samples were
taken with a sterile pipette within the same laminar flow hood.
Bioreactors were assembled, sealed, and then autoclaved to ensure sterilization.
Additions and samples were made through sterile valve connections that were attached to
the vessel before autoclaving. Headspace pressure was used to draw out the sample and a
series of clamps were used to ensure that no contamination occurred.
Now that the key material, equipment, and methods have been detailed the next chapter will
discuss how these things were used to conduct the experiments for this project.
Chapter 5: Strategy to Evaluate High Cell Density Infection of Batch
Grown Cells
In an attempt to improve the overall process yield, the goal of this evaluation is to determine if a
batch generated cell culture can be infected at a higher cell density than the current fed-batch
process allows and if that higher cell density at infection leads to higher yields. The following
chapter will discuss the approach used to determine the feasibility of batch cell growth for high-
density infection, present the results from the experiments conducted, and then analyze and
summarize the results.
5.1 Approach
The approach for this project is outlined in the graphic below and can be broken into the
two key components of high-density batch cell growth followed by high-density infection. The
first step is to determine the feasibility of generating a high density cell culture from a batch
process at a small shaker flask scale and then explore the addition of other supplements.
Following small scale optimization is bioreactor replication which then allows for the final
phase of high-density infection. When the one liter bioreactor experiments failed to produce
positive results, the project focus shifted to scale-up exploration and eventually small scale
reproducibility.
- Glucose Optimization
- Additional Supplement Explc
- Bioreactor Replication
- High-density Infection
Figure 3: Approach
5.1.1 Experiment 1: Glucose Screening in Shaker Flasks
If glucose feeding is required for high density cell growth in a standard fed-batch
process, the batch process will require a substantial amount of initial glucose. For both
equipment scheduling and economic reasons the initial glucose screen took place in 250 mL
shaker flasks. Within each flask was added a dilution of cells in the current cell growth
media at the standard starting cell density with a total culture volume of approximately 100
mL. Next, concentrated glucose was added to adjust the initial glucose level between the
standard fed-batch level and eight times the standard level as seen Table 2: Experiment 1 -
Design.
Table 2: Experiment 1 - Design
1 0
2 200
3 300
4 500
5 700
6 800
These samples were then cultivated by agitating the flasks on a shaker plate placed inside an incubator that
controls temperature and headspace CO 2. Peak cell concentration was achieved after more than seven days of
cultivation. A daily sample was pulled from each flask to measure the parameters listed in
Appendix 2: Experiment Test Information.
For cell growth experiments, viable-cell concentration was used as the primary
response parameter with the assumption that more cells available for infection will lead to a
higher final yield. While this parameter may not correlate directly to final yield, no better
measurement is available at the smaller laboratory scale because these samples are not large
enough to infect and process through downstream.
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Figure 4: Experiment 1 Results - Cell Density vs. Time
As seen in Figure 4: Experiment 1 Results - Cell Density vs. Time, the cell
concentration of the batch processes with additional glucose far exceeded the typical fed-
batch cell concentration of 100%. By plotting the peak cell concentration achieved for each
experiment, as seen in Figure 5: Experiment 1 Results - Peak Cell Density vs. Initial
Glucose, we can see that the optimal initial glucose concentration is slightly more than five
times greater than the original initial glucose concentration. Going forward, all experiments
will be centered around an initial glucose concentration that is five times greater than the
standard initial glucose concentration.
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5.1.2 Experiment 2: Media Supplement Screening in Shaker Flasks
Using the optimal initial glucose concentration from the first experiment results as a
starting point, additional factors were then screened in similar shaker flask experiments.
The purpose of this set of experiments was to identify key parameters that influence cell
growth. Discussions with a number of company personnel, along with a literature review of
animal cell cultures, determined that the parameters to screen first were amino acids,
vitamins, and trace metals. A full factorial DOE with three centerpoints was then used to
screen these three factors along with a narrow range of glucose addition as the fourth factor.
The experimental layout can be seen in Table 3: Experiment 2 - Glucose, Trace Metals,
Amino Acids, and Vitamins.
800%
Table 3: Experiment 2 - Glucose, Trace Metals, Amino Acids, and Vitamins
For this experiment, the standard culture media was used and various additives were
used to change the composition of this media. Another option would have been to use a
different culture media with the desired composition. The decision to use the current culture
media as a base and add various elements individually, rather than to use a new culture
media, was driven from a validation perspective. The change management requirements to
make modifications to the current media formulation is significantly less work than the
work required to implement a new media culture.
A full factorial DOE was used during this exploratory DOE stage because shaker
flasks are more economical than bioreactor experiments making them a more cost effective
way to identify interactions between parameters. As with Experiment 1, within each flask
was a total culture volume of approximately 100 mL consisting of the current growth media,
cells, and additional components according to the DOE criteria. For Trace Metals, Amino
Acids, and Vitamins, - signifies that no additional amount of that component is added. The
+ signifies that concentrations of that parameter were increased between 20% and 50%
through the use of concentrated solutions. 0 signifies a parameter increase at the midpoint
between - and +. For glucose, 0 signifies the optimal concentration determined from the
previous experiment, a 500% of the growth media's initial glucose concentration, and the -
and + symbol signify a 10% concentration decrease and increase from that value,
respectively.
As seen in Figure 6: Experiment 2 Results - Cell Density vs. Time, the average results
from the three midpoint runs from Experiment 2: Media Supplement Screening in Shaker
Flasks were nearly 2.5 times better than the traditional fed-batch process.
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Figure 6: Experiment 2 Results - Cell Density vs. Time
A linear regression will be performed to analyze a number of experiments in this
thesis. Details of the analysis for Experiment 2: Media Supplement Screening in Shaker
Flasks, including the steps to validate the regression, will be reviewed here. All future
linear regression results, following this same model confirmation steps, will be listed in the
appendix and referenced throughout the thesis.
For Experiment 2: Media Supplement Screening in Shaker Flasks, cell density is the
response parameter and initial glucose concentration, amino acid content, vitamin content,
and trace metal content are the independent variables. After generating the regression
model using JMP 8.0 and eliminating parameters that do not significantly impact the model,
the final regression results can be seen in Appendix 3: Experiment 2 - Statistical Analysis of
Glucose, Trace Metals, Amino Acids, and Vitamins. The first model output to verify is the
F test to confirm that the response parameter significantly depends on the model parameters.
With an F test value of 7.18 with a p value of less than 0.05 we may conclude that the
response parameter does depend on the model parameters.
The next model confirmation is the R2 value which indicates how well the model fits
the data. An R2 value of 0.9349 indicates that we have captured most of the variance with
the model and the adjusted R2 of 0.8047 indicates that we have not overfit the model.
Next, a plot of the residuals versus prediction, row, and each of the effects all show
the residuals to be randomized and not systematic. Furthermore, a look at the normal plot of
the residuals indicates that there are no residual outliers because all points are contained
within the 95% confidence band and seem to follow a random pattern along the line.
Having confirmed that our model is sound, a look at the t-test indicates which of the
modeled parameters most influence the response parameter. The t-test values indicate that
the addition of a trace metal supplement hinders cell growth and that glucose is the only
other significant factor influencing cell growth and all other main effects and interactions
are insignificant.
As seen in Figure 7: Experiment 2 Results - Glucose and Cell Density vs. Tim,
glucose is still available in the culture when cell growth slows and eventually stops. While
the regression model undoubtedly proves that glucose is a dominating factor for cell growth,
it fails to identify the limiting or inhibiting parameter preventing further cell growth.
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Figure 7: Experiment 2 Results - Glucose and Cell Density
vs. Time
Additional trends of measurements taken during this experiment are available in
Appendix 4: Experiment 2 - Cell Density vs. Time through
Appendix 11: Experiment 2 - Glutamic Acid vs. Time. The final conclusion to draw
from this experiment is that batch cell growth is achievable with the standard cell growth
media and the addition of trace metals, amino acids, and vitamins did not significantly
improve this growth. As was show in Experiment 1: Glucose Screening in Shaker Flasks,
and confirmed in this experiment, the key parameter in batch cell growth is the initial
glucose concentration. The next step is the replication of these results in a one liter
bioreactor so that infection experimentation can occur.
5.1.3 Experiment 3: Bioreactor Replication
Shaker flasks, while cost effective and easy to use, have a number of differences from
the bioreactors used by the manufacturing process. Experiment 3 aims to replicate, in a one
liter bioreactor, the shaker flask results of Experiment 1: Glucose Screening in Shaker
Flasks and Experiment 2: Media Supplement Screening in Shaker Flasks. Bioreactors,
compared to shaker flasks, allow for additional process controls including the control of
PO2, pH, temperature, and stir speed. Bioreactors also use a different CO 2 scheme from
shaker flasks.
pH control, PO2 setting, and temperature setting were chose for the initial DOE and a
half factorial was used to allow for the maximum amount of screening of the main effects
with the minimum amount of runs as seen in Table 4: Experiment 3 - pH control, pO2, and
Temperature.
Table 4: Experiment 3 - pH control, PO2, and Temperature
1 Control +-
2 Control - +
3 No Control - -
4 Control 0 0
5 No Control + +
6 Control - +
7 No Control -
8 No Control + +
9 Control + -
Control of pH was one of the tests selected because of the difference between how
CO 2 is controlled with shaker flasks and bioreactors. The bioreactor system controls pH by
introducing CO 2 into the overlay gas when the pH is too high and base, 0.5 M sodium
hydroxide, when the pH is too low. In a shaker flask, the percent of CO 2 in the overlay gas
is held at a constant 5% and otherwise pH is not controlled. For this DOE, pH was set for
runs labeled Control and not set, or no pH controls were used, for runs labeled No Control.
PO2 was selected because previous experiments with these shaker flasks suggested
that the agitation required for good cell mixture results in a PO2 that is significantly higher
than the typical setting for a bioreactor 1. The PO2 setpoint was varied from 70% of the
normal value to 130% of normal, represented by - and +, with a midpoint of 100%,
represented by 0.
Temperature was selected because in past bioreactor experiments temperature is often
a key parameter 1. Temperature was varied from 0"C to 1 "C, represented by - and +, with a
midpoint of 0.5"C, represented by 0.
As seen in Figure 8: Experiment 3 - Cell Density vs. Time, the results from the
bioreactor replication show that cell growth in the bioreactors was significantly lower than
cell growth in shaker flasks. The graph also clearly shows that turning off the pH controller
negatively impacts cell growth, which is also confirmed by the regression analysis seen in
Appendix 12: Experiment 3 - Statistical Analysis of pH, p02, Stir Speed, and Temperature.
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Figure 8: Experiment 3 - Cell Density vs. Time
The failure of the bioreactor to reproduce the positive shaker flask results created the
need for another bioreactor DOE. As previously detailed, the CO 2 control scheme for a
bioreactor is different from the control scheme of a shaker flask. Equipment availability
limited this special testing to one bioreactor, but an attempt was made to more realistically
replicate the CO 2 control scheme of a shaker flask in a bioreactor. To do this, a pump
capable of delivering a constant flow of 5% CO 2 was attached to the bioreactor's overlay
gas. Stir speed was also increased to 190% of the normal rotations per minute in this one
bioreactor to try to simulate the excessive agitation of a shaker flask. In addition to this one
bioreactor, a typical DOE was setup to test a lower pH value, higher stir speeds, and a wider
variety in temperature. The design can be seen in Table 5: Experiment 3 - Stir Speed,
Temperature, and C02 Control. Stir speed varies from 100% of the normal rotations per
minute to 190%, designated - and +, and temperature varies from -4'C to 0"C, designated -
and +.
Table 5: Experiment 3 - Stir Speed, Temperature, and CO 2 Control
1 - - Normal -0.1
2 + + Normal -0.1
3 + - Normal -0.1
4 - - Normal -0.1
5 + + 5% Constant None
Like the first bioreactor replication DOE, as can be seen in Figure 9: Experiment 3 -
Cell Density vs. Time, none of the bioreactors matched the results achieved with shaker
flasks in Experiment 2: Media Supplement Screening in Shaker Flasks.
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Figure 9: Experiment 3 - Cell Density vs. Time
A regression analysis of all of the experiments with a controlled pH set point, as seen
in Appendix 13: Experiment 3 - Bioreactors with pH Control - Statistical Analysis of
Temperature, pH, PO2, and Stir Speed, demonstrates that temperature, pH, p0 2, and initial
glucose concentration do have a significant effect on batch cell growth. However, the effect
of these parameters on cell density is small relative to the difference between the cell
densities achieved in Experiment 2: Media Supplement Screening in Shaker Flasks and
Experiment 3: Bioreactor Replication.
Graphs of all key tests for this experiment can be seen in Appendix 14: Experiment 3
- Cell Density vs. Time through Appendix 21: Experiment 3 - Glutamic Acid vs. Time and
observations from these charts are included in Appendix 24: Comparison of Shaker Flasks
from Experiment 2 and Bioreactors from Experiment 3. While the table discusses all of the
major parameters, the key takeaways are that glucose consumption was higher in the
bioreactors despite producing fewer cells than the shaker flasks, lactate and ammonium
production are tied to the bioreactors settings and at higher levels may be inhibiting growth,
and media age may be influencing cell growth.
To explore potential scale-up inhibiting parameters, Appendix 25: Comparison of
Shaker Flask and Bioreactor Systems offers a comparison of the shaker flask system with
the bioreactor system. Of the system parameters compared, the most promising parameters
to explore are the ones influencing CO 2. The next step is to run bioreactors and shaker
flasks, filled with the same culture source, in parallel while measuring CO 2 to try to
understand the difference between the two systems.
5.1.4 Experiment 4: Parallel Experiments with Shaker Flasks and
Bioreactors
While the past experiments have shown that cell growth in Experiment 3: Bioreactor
Replication is significantly less than cell growth in Experiment 2: Media Supplement
Screening in Shaker Flasks, the reason for this disparity is still not yet clear but the most
promising parameters to test are those that influence dissolved CO 2. The next experiment
was designed to test shaker flasks and bioreactors in parallel by filling both vessels with the
same pre-culture. The bioreactor setups can be seen in Table 6: Experiment 4 - Bioreactor
Setup and the shaker flask setups can be seen in Table 7: Experiment 4 - Shaker Flask
Setup.
Table 6: Experiment 4 - Bioreactor Setup
100% 1 0 100% Normal 1 -0.1 0.57
100% 0 100% Normal -0.1 0.40
Table 7: Experiment 4 - Shaker Flask Setup
Pulled trom
bioreactor Shaker Flask Polycarbonate 0.50 0%
Pulled from Shaker Flask Polycarbonate 0.50 0%
bioreactor
Pulled from Shaker Flask
bioreactor Polycarbonate 0.50 6%
Pulled from Shaker Flask
bioreactor Polycarbonate 0.50 12%
Pulled from Shaker Flask
bioreactor Polycarbonate 0.50 23%
Pulled from Shaker Flask
bioreactor Polycarbonate 0.50 46%
Control Shaker Flask Polycarbonate 0.50 -
Control Shaker Flask Polycarbonate 0.50 -
Control Shaker Flask Polycarbonate 0.50 -
Control Shaker Flask Polycarbonate 0.50 -
Material Shaker Flask Glass 0.50 -
Shape and
Surface/Liquid
Volume Ratio 1 L Bottle Glass 0.57 -
Shape and
Surface/Liquid
Volume Ratio 2 L Bottle Glass 0.98 -
Shape and
Surface/Liquid
Volume Ratio 100 mL Bottle Glass 0.87 -
Agitation Internal Stir
Method Bottle Glass 0.51 -
As seen in the experimental design, also explored are different surface area to liquid
volume ratios in the bioreactors and vessel shape, material, and surface area to liquid
volume in the shaker flasks. Included is also a set of shaker flask experiments that contain
culture that was removed from batch bioreactors at different points during the reaction. The
purpose of this is to determine at what point in time during the cell growth in the bioreactor
are the contents of the culture exhausted or altered into a culture that is not longer able to
achieve the high density growth achieved in Experiment 2: Media Supplement Screening in
Shaker Flasks. As seen in Figure 9: Experiment 3 - Cell Density vs. Time, there is a clear
difference in cell growth between the shaker flask and bioreactor visible before time reaches
40%.
One final component incorporated into this experiment is the measuring of dissolved
CO 2 and 02 in both the shaker flasks and bioreactors. Measuring CO 2 is not a typical
procedure at the lab where these experiments were conducted and a measuring device was
not available before this experiment.
Like the previous bioreactor experiments, the bioreactors in this experiment, as seen
in Figure 10: Experiment 4 - Cell Density vs. Time, failed to reach the same cell growth
that was achieved in Experiment 2: Media Supplement Screening in Shaker Flasks.
Surprisingly, the shaker flask controls also failed to repeat the cell growth from Experiment
2: Media Supplement Screening in Shaker Flasks.
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Figure 10: Experiment 4 - Cell Density vs. Time
A linear regression of the experiment, seen in Appendix 26: Experiment 4 - Statistical
Analysis of Vessel, Material, and Time Pulled from Bioreactor, shows the impact of the
parameters tested in this experiment, but with the shaker flask controls failing to reach a
high cell density, the more obvious learning from this experiment is that the results achieved
in Experiment 2: Media Supplement Screening in Shaker Flasks are not consistent and an
unknown parameter is influencing cell growth.
Graphs of all key tests for this experiment can be seen in Appendix 27: Experiment 4
- Cell Density vs. Time through Appendix 35: Experiment 4 - pCO2 vs. Time and
observations from these charts are included in Appendix 36: Comparison of Shaker Flasks
from Experiment 2 and Experiment 4. Of the parameters compared, the most promising
parameter to explore is the influence of media age and the influence of the starting
concentration of glutamine and ammonia as those concentrations are influenced by media
age. The next step is to run shaker flask experiments with media of a different age as well
as with different initial concentrations of ammonium, glutamine, and lactate.
5.1.5 Experiment 5: Media Age, Lactate, Ammonium, and Glutamine
Exploration
Media age is a parameter that stands out when analyzing why the control samples
from Experiment 4: Parallel Experiments with Shaker Flasks and Bioreactor do not repeat
the results seem in Experiment 2: Media Supplement Screening in Shaker Flasks. Cold
storage of media extends the useful life of media and while all media used for these
experiments were within the useful life of the product, Appendix 30: Experiment 4 -
Ammonium vs. Time and Appendix 33: Experiment 4 - Glutamine vs. Time, shows the
difference between the starting level of glutamine and ammonium due to the degradation of
glutamine over three months. While ammonium and lactate have been to inhibit MDCK
cell growth the ammonium and lactate levels cited in the study are significantly higher than
the levels seen in the shaker flask and bioreactor experiments of this study 7 . Nevertheless,
the influence of media age, glutamine, lactate, and ammonium on cell growth will be
explored and the experimental setup can be seen in Table 8: Experiment 5 - Media Age,
Lactate, Ammonium, and Glutamine.
Table 8: Experiment 5 - Media Age, Lactate, Ammonium, and Glutamine
1 221 9SP1061 No 1 1
2 221 9SP106I No 2 1 -
3 221 9SP1061 No 3 1 -
4 221 9SP1061 No 1 2 -
5 221 9SP1061 No 2 2 -
6 221 9SP106I No 3 2 -
7 221 9SP1061 No 1 3
8 221 9SP1061 No 2 3
9 221 9SP1061 No 3 3
10 144 9SP140C No - 1
11 144 9SP140C No 1 -
12 144 9SP140C No 1 1 -
14 144 9SP140C No 1 1 +
15 144 9SP140C No - - -
16 144 9SP140C No - - -
17 221 9SP1061 No - - -
18 144 9SP140C No - - -
19 221 9SP1061 Yes - - .
20 144 9SP140C Yes - - -
As seen in the experimental design, the normal media, lot 9SP 1061, is at the time of
this experiment 221 days old and the newer media, lot 9SP140C, is 144 days old. Samples
1-9 vary the initial ammonium and lactate levels, with 1, 2, and 3 representing 100%, 225%,
and 350% for lactate and 1, 2, and 3, representing 200%, 350%, and 450% for ammonium.
Samples marked with - did not have their ammonium or lactate adjusted. Samples 10-14
attempt to simulate starting levels for ammonium, lactate, and glutamine of the older media
with the newer media. For glutamine, + indicates an initial glutamine level of 133% and -
indicates no adjustment made to glutamine. Samples 19 and 20 test the influence of pre-
charging the media the day before the cells are charged.
Graphs for this experiment can be seen in Appendix 39: Experiment 5 - Cell Density
vs. Time through Appendix 46: Experiment 5 - Glutamic Acid vs. Time and observations
from these charts are included in Appendix 47: Discussion of Results from Experiment 5.
Figure 11: Experiment 5 - Cell Density vs. Time shows that once again the control shaker
flasks failed to achieve the results of Experiment 2: Media Supplement Screening in Shaker
Flasks.
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Figure 11: Experiment 5 - Cell Density vs. Time
We also see that the control experiments from both media lots further demonstrates
the variability of batch cell growth as the new media lot does not even reach a cell density
of 100% while the older media reaches about 135% for no explainable reason. Also seen is
the clear influence that initial ammonium has on cell growth which is further confirmed by
the linear regression seen in Appendix 38: Experiment 5 - Statistical Analysis of Glutamine,
Lactate, Ammonium, and Media Age.
While there are further avenues to explore to try to account for the difference seen
between Experiment 2: Media Supplement Screening in Shaker Flasks and all following
experiments, time constraints forced this project to conclude.
5.2 Summary of Results
Experiment 1: Glucose Screening in Shaker Flasks determined the optimal starting
glucose range using shaker flasks and was followed by Experiment 2: Media Supplement
Screening in Shaker Flasks, another shaker flask experiment, which ruled out other supplements
improving batch cell growth. Through the first two experiments the results achieved were
excellent. Next, Experiment 3: Bioreactor Replication attempted to scale up the batch process
to a one liter bioreactor while testing the influence of a number of adjustable parameters. When
no ideal conditions were found for a bioreactor to replicate the initial results, Experiment 4:
Parallel Experiments with Shaker Flasks and Bioreactors attempted to run bioreactors and
shaker flasks in parallel to eliminate as many differentiating parameters as possible.
Surprisingly, the shaker flasks controls from Experiment 4 failed to reproduce the results from
Experiment 2: Media Supplement Screening in Shaker Flasks. After testing the most prominent
difference between Experiment 2: Media Supplement Screening in Shaker Flasks and
Experiment 4: Parallel Experiments with Shaker Flasks and Bioreactors, media age and
associated parameters, with shaker flasks and finding no conclusive reason for the variability
the project was concluded due to time constraints.
Conclusion
Despite the negative results of this thesis, batch cell growth of MDCK still has potential as a
process going forward. While the results were not consistent, the positive results observed from
the experiment deem further exploration. Past experimental data has shown that a higher cell
density at infection results in a higher final yield, and the batch process has shown its potential to
reach higher cell densities, though inconsistently. It is important to note that the cause of the
variation could be something that has always existed in the fed-batch process. Nearly every batch
experiment achieved the cell density target of a fed-batch process. Variability occurred at cell
densities above the typical operating range of a fed-batch process, so all aspects of the process
should be considered as potential sources of variability. Further research is needed to identify
what is causing the variability in results but given the potential improvement to the
manufacturing process, this exploration is justifiable.
Appendix
Appendix 1: Raw Material Information
R7131 Amino Acids Solution 50X Sigma 049K2411
33016 MDCK CDM Lonza 9SP 1061 Manufactured on 4/27/09
33016 MDCK CDM Lonza 9SP140C Manufactured on 7/13/09
Glucose Solution Internal SOP105098 0100 400 g/L
L-Glutamine Sigma 45K23141
L4263 Sodium DL-Lactate Sigma 116K53064 Approx. 98%, 60% (w/w)
Trace Element Solution 50X Gibco 1175172
R7256 Vitamin Solution IOOX Sigma 019K2380
A7219 L-Aspartic acid Sigma 079K0 104
G8415 L-Glutamic acid Sigma 128K0018
V0513 L-Valine Siga 078K0039
A8094 L-Arginine Siga 078K0178
69775 Lactic acid Sigma 1433079 41209P09
P2126 L-Phenylalanine Sigma 000144-3420
22, 122-8 Ammonium hydroxide solution Sigma S87552-259
Appendix 2: Experiment Test Information
Vi-Cell Analyzer Cell Viability % Live Cells -
Vi-Cell Analyzer Total Cell Concentration cells/mL Percentage of fed-batch target peak cell density
Vi-Cell Analyzer Viable Cell Concentration cells/mL Percentage of fed-batch target peak cell density
Vi-Cell Analyzer Cell Diameter microns
Off-line pH probe Off-line pH -loglo[H ] Difference from standard pH
NOVA Analyzer Glutamine Percentage of initial fed-batch value
NOVA Analyzer Glutamic Acid Percentage of initial fed-batch value
NOVA Analyzer Glucose Percentage of initial fed-batch value
NOVA Analyzer Lactate Percentage of initial fed-batch value
NOVA Analyzer Ammonium g/L Percentage of initial fed-batch value
NOVA Analyzer Osmolality mOsm/kg Percentage of initial fed-batch value
Manual Reading Incubator Temperature C Difference from standard temperature
Manual Reading Shaker plate rev/min Percentage of initial fed-batch value
Manual Reading Culture volume mL
Manual Reading Time Days Percentage of standard fed-batch reaction time
Appendix 3: Experiment 2 - Statistical Analysis of Glucose, Trace Metals, Amino Acids, and Vitamins
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Appendix 4: Experiment 2 - Cell Density vs. Time
2 0% 2.. 4 - 0- -- . 00~ 2 4 6.
50% --
5 0% --- - ... - . -----.. .......
.... ..
0% - 0 ~~ % ~~~ 8% 1M. 10 14% 6% 9% 2 %
Time
Appendix 6: Experiment 2 - Lactate vs. Time
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Appendix 9: Experiment 2 - Osmolality vs. Time
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Appendix 11: Experiment 2 - Glutamic Acid vs. Time
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Appendix 12: Experiment 3 - Statistical Analysis of pH, pO2, Stir Speed, and Temperature
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Appendix 13: Experiment 3 - Bioreactors with pH Control - Statistical Analysis of Temperature, pH, P 0 2, and Stir Speed
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Appendix 14: Experiment 3 - Cell Density vs. Time
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Appendix 16: Experiment 3 - Lactate vs. Time
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Appendix 15: Experiment 3 - Glucose vs. Time
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Appendix 17: Experiment 3 - Ammonium vs. Time
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Appendix 18: Experiment 3 - pH vs. Time
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Appendix 20: Experiment 3 - Glutamine vs. Time
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Appendix 19: Experiment 3 - Osmolality vs. Time
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Appendix 21: Experiment 3 - Glutamic Acid vs. Time
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Appendix 24: Comparison of Shaker Flasks from Experiment 2 and Bioreactors from Experiment 3
There is a clear difference between cell growth that occurs between day two and day three. Graphing cell growth on
a log scale versus time shows that both experiments three phases of growth but the initial cell growth phases lasts for
Cell Density only two days with the bioreactors where it lasts for three days in the shaker flasks. The second growth phase,
which lasts three days and is a lower growth rate than the first phase, and the plateau phase, where growth stops,
-4--Shaker
FI..k
-*-PH-0.1,
TO
-- pH-0. 1,
T-4
No pH
5% C02
IVCC
seem to be similar between the two experiments.
The same lot of glucose was used for the raw material for both experiments. The specific glucose chart graphs
glucose versus the amount of cell produced for a given amount of time. As the trend line becomes more vertical it
Glucose means that more glucose is consumed per cell and more horizontal means that less glucose is consumed. The
specific glucose chart shows that the shaker flask samples have three distinct phases, which matches the cell growth
chart. The bioreactor samples only have one phase of high glucose consumption.
Lactate is one area where the shaker flasks and bioreactors seem to differ greatly. The lactate trend for the shaker
flasks seems to follow the three growth phases with three days of significant lactate production during the initial
growth phase, followed by four days of slow production during the second growth phase, and finally a decrease of
lactate during the plateau phase. The lactate produced by shaker flasks levels off below 1,200%, which past
Lactate experience shows that lactate concentration above this level can negatively impact the infection stage18 . Lactate
production for the bioreactors shows a similar pattern to shaker flask lactate production, but the different phases do
not match the growth phases observed on the cell growth graph and the lactate production levels off at significantly
higher value in the bioreactors than in the shaker flasks. Lactate, as well as in conjunction with ammonium, is
19known to negatively influence MDCK cell growth so this may require further exploration
Ammonium production in the shaker flask and bioreactor experiments seems to follow a similar trend. The lower
Ammonium temperature bioreactors, which grew to a low cell density, have noticeably lower ammonium production which may
be a factor of the lower temperature setting, the lower cell production, or some combination of both factors. This
may require further exploration.
While pH is controlled in a bioreactor, the actual value, as determined by an offline probe, does not always match
pH the online measurement and the online probe must be recalibrated. The offline bioreactor measurements compared
to the shaker flask measurements show similar ranges and trends.
The osmolality trend is also significantly different between the bioreactors with pH control and the shaker flasks and
Osmolality bioreactors without pH control. This is not surprising as the bioreactor pH is controlled with NaOH which increases
the osmolality as it is added.
Glutamine consumption seems to be similar between the two experiments. The bioreactors that grew significantly
Glutamine
less cells also consumed less glutamine, as is to be expected.
Glutamic Glutamic acid is production seems to be similar between the two systems. It rises during cell growth and then is
Acid fully consumed as the plateau growth phase is reached after which it begins to rise again.
The CDM used in both experiments came from the same production lot. The bioreactor experiments occurred 49
and 82 days later than the shaker flask experiments. While the CDM is stored at 4"C to reduce influence of aging, it
CDM Age is possible that the media composition has changed enough to influence cell growth. A look at the starting value for
glutamine and ammonium shows that the later experiments have a lower glutamine concentration and higher
20
ammonium concentration, which is not surprising as glutamine degradation produces ammonium
Cells pulled from the working cell bank for both experiments were 7-12 days removed from the freezing process and
PDL of
had been doubled between 20 and 30 times, which is well within the verified range. While there is a slight
Pre-Culture
difference between the cell age of the cells used for the shaker flasks and the bioreactor, the difference is slight and
Cells
unlikely to be influential.
Appendix 25: Comparison of Shaker Flask and Bioreactor Systems
Temperature of the incubator
atmosphere is controlled and this
maintains the temperature of the
shaker flasks contents stored within
the incubator. Direct measurement of
the samples on the shaker plate
indicates that the temperature of the
cell culture is 0.5'C higher than the
incubator set point. This higher
temperature is caused by the shaker
plate, which generates a small amount
of heat.
Temperature is controlled by
maintaining the temperature of water
that is pumped into jacket surrounding
the bioreactor.
The range of values tested in the
bioreactors without achieving high-
density cell growth indicates that
temperature is not the limiting factor
preventing high-density growth.
Oxygen is provided by the atmosphere Oxygen is provided by the overlay gas The range of values tested in the
and transfer between the air and the and controlled by adding additional bioreactors without achieving high-
sample is maintained uniformly by oxygen through a sparger at the density cell growth indicates that
vigorous agitation of the sample. Past bottom of the bioreactor directly oxygen is not the limiting factor
experience places the above 75% below the internal stirrer. Percent preventing high-density growth.
dissolved 022. dissolved 02 is measured continuously
by the Q+ system and maintained at
the set point.
Agitation is provided by an external Agitation is provided by an internal The range of values tested in the
orbital shaking device. stirrer. bioreactors without achieving high-
Temperature
CO 2 is controlled to a constant 5% in
the atmosphere within the incubator
dissolved C0 2, which is transferred
between the air and the sample, is
maintained by vigorous agitation of
the sample.
CO2 is controlled by adding CO 2 gas
to the gas overlay mixture when
directed to by the Q+ system. Overlay
gas CO 2 content is part of the pH
control scheme in the Q+ system.
CO2 is added to the overlay gas,
which then transfers to the sample,
when the pH is above the set point.
density cell growth indicates that stir
speed is not the limiting factor
preventing high-density cell growth.
There is difference between the way
dissolved CO 2 is controlled in the two
systems. The bioreactor experiment
with high agitation and an overlay
containing a constant 5% CO 2 was an
attempt to replicate the settings of a
shaker flask. The results of this
experiment were not positive and
additional study of dissolved CO 2 is
required.
The buffer system included in the The bioreactor system uses CO 2 gas Experimental data shows that pH is an
CDM package provides some pH and liquid NaOH to maintain a important parameter for cell growth
control, but otherwise pH is constant pH. The bioreactor pH but turning the pH control system off
uncontrolled and changes as cell sensor has to be recalibrated when the in the bioreactor did not promote cell
pH growth occurs. offline measurement does not match growth. When the bioreactor pH
the online measurement. control system is turned off the only
CO 2 provided to the system is
atmospheric CO 2 provided through the
gas overlay. It is possible that when
Carbon
Dioxide
the pH control system was turned off,
CO 2 was exhausted and this limitation
inhibited cell growth.
Oxygen and CO 2 is controlled in a Oxygen is controlled through sparging This difference between these ratios
shaker flask by reaching equilibrium so it is not influenced by the surface may explain why a bioreactor is not
Surface Area with the atmosphere within the area to liquid volume ratio, but CO 2 is able to get as much 
CO 2 transferred
incubator. This exchange between the controlled through overlay gas so it is into the liquid from the overlay gas, if
tolud sample and the atmosphere occurs influenced. The surface area to liquid that were an issue. More explorationVolume
through the surface area of the volume ratio in a shaker flask is 0.4 on this is needed.
Ratio
sample. The surface area to liquid cm 2/mL.
volume ratio in a shaker flask is 0.5
cm 2/mL.
Shaker flasks are filled by first adding Bioreactors are filled by first adding There is no difference between the
warmed media and glucose to a flask. warmed media and glucose to a steps taken to generate the samples or
Filling Then, a sample of cells is added, the vessel. Then, a sample of cells is the time required to prepare each
Procedure mixture is sampled, and the flask is added, the mixture is sampled, and the sample.
immediately placed into the incubator. contents are immediately transferred
to the vessel.
Shaker flasks are Erlenmeyer flasks Bioreactors are cylindrical shaped While the shape of the vessel is
and thus shaped like an upside down with an internal top-stirrer placed in unlikely to be a significant factor,
Vessel Shape
cone. The vessels also have ridges the center of the vessel. there is a slight difference that can be
along the inside of the bottom to act as further explored.
baffles and aid in mixing.
Shaker flasks are made out of Bioreactors are made out of glass. While the material of the vessel is
Vessel polycarbonate. unlikely to be a significant factor,
Material there is a slight difference that can be
further explored.
Shaker flasks are kept in a closed The glass bioreactors are exposed to Past experience has shown that the
incubator with no exposure to light. fluorescent lighting during work media and cell line are not light
Light
hours. sensitive, but this is a difference
Exposure
between the two systems that can be
further explored.
Appendix 26: Experiment 4 - Statistical Analysis of Vessel, Material, and Time Pulled from Bioreactor
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Appendix 27: Experiment 4 - Cell Density vs. Time
150% -
Exp 2
*Bioreactor
-ShakerContol
-+4-Shaker Pulled from Bio
-NGlassShaker
L Bottle
-2 L B1ttle
100. mLBottle
SStir Bottle
0% -- - - - - - , - - - - - -.-- -..-.- , ............w--....----, -.-- ------ - - - - - ..- - .- ..., - .-- - " .- - -- - *- - -
0% 20% 40% 60% 80% 100% 120% 140% 160% 180% 200%
Time
Appendix 29: Experiment 4 - Lactate vs. Time
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Appendix 28: Experiment 4 - Glucose vs. Time
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Appendix 30: Experiment 4 - Ammonium vs. Time
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Appendix 31: Experiment 4 - pH vs. Time
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Appendix 33: Experiment 4 - Glutamine vs. Time
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Appendix 32: Experiment 4 - Osmolality vs. Time
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Appendix 34: Experiment 4 - Glutamic Acid vs. Time
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Appendix 36: Comparison of Shaker Flasks from Experiment 2 and Experiment 4
Clearly the samples from Experiment 4 did not grow as well as the samples in Experiment 2. Again, the
separation between the experiments seems to occur between a time of 40% and 80%.
Cell Density
Glucose
The graph of glucose concentration versus time shows that despite the difference in total cells grown, samples
from both Experiment 2 and Experiment 4 run out of glucose at similar points in time which indicates that
Experiment 4 samples consumed glucose less efficiently than samples from Experiment 2.
Appendix 35:
300%
Lactate Aside from the bioreactors, all samples from Experiment 4 display a similar lactate concentration trend to the
samples from Experiment 2.
Ammonium is similar to glutamine in that the starting concentration levels are different between Experiment 2
and Experiment 4. Experiment 4 starting levels are higher than starting levels for Experiment 2, which makes
Ammonium sense as the degradation of glucose produces ammonium. Aside from the starting levels, ammonium trends
between Experiment 2 and Experiment 4 are similar, thought the difference in starting concentration may be
22significant as ammonium is known to inhibit cell growth
pH for a majority of the flasks from Experiment 4 appears to follow the same trend as pH from Experiment 2.
The only serious deviations are with the controlled bioreactors and the spinner flask and 100 mL bottle.
Aside from the bioreactors, all samples from Experiment 4 display a similar osmolality concentration trend to the
samples from Experiment 2.
Glutamine concentration in Experiment 2 starts ~-16% higher than the glutamine concentration in Experiment 4.
Glutamine This difference in starting value is likely due to the age of the media as glutamine degrades over time even when
kept in cold temperature storage. Aside from the difference in starting concentrations the glutamine trend
between Experiment 2 and Experiment 4 appear relatively similar.
Glutamic Acid Glutamic acid follows a similar trend between Experiment 2 and Experiment 4.
The same lot of CDM was used for both Experiment 2 and Experiment 4. At the time Experiment 2 was
conducted the media used was 79 days old and at the time Experiment 4 was conducted the media was 205 days
old. While the media was stored in near freezing temperature during this time period and is within the acceptable
usage period that this process has been verified, this is a difference that should be investigate further.
PDL of Pre- Cells used for Experiment 4 were 25 days removed from the freezing process and had been doubled 45 times
Culture Cells while cells used for Experiment 2 were 7 days removed and had been doubled 20 times. Both of these values are
well within the limits of the Novartis process for this cell line, so this difference is not likely to be a significant
factor. Also, the statistical analysis seen in Appendix 37: Statistical Analysis of All Blank Shaker Flasks shows
that pre-culture cell age is not an influential factor.
Appendix 37: Statistical Analysis of All Blank Shaker Flasks
Summary ofFit Sorts
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Appendix 38: Experiment 5 - Statistical Analysis of Glutamine, Lactate, Ammonium, and Media Age
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Appendix 39: Experiment 5 - Cell Density vs. Time
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Appendix 41: Experiment 5 - Lactate vs. Time
Appendix 40: Experiment 5 - Glucose vs. Time
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Appendix 42: Experiment 5 - Ammonium vs. Time
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Appendix 43: Experiment 5 - pH vs. Time
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Appendix 45: Experiment 5 - Glutamine vs. Time
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Appendix 46: Experiment 5 - Glutamic Acid vs. Time
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Appendix 44: Experiment 5 - Osmolality vs. Time
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Appendix 47: Discussion of Results from Experiment 5
Again, the samples did not grow as well as Experiment 2 and the separation between the experiments seems to
occur between a time of 40% and 80%. Surprisingly, there is a substantial difference between the new media and
old media, where we would have expected identical results.
Glucose The samples in Experiment 2 consumed glucose faster than the samples in Experiment 5 which is expected as
fewer cells grew in Experiment 5. No major difference is observed between the samples of Experiment 5.
While lactate levels started differently, all samples followed a similar trend and leveled off at a similar value.
Lactate The analysis seen in Appendix 38: Experiment 5 - Statistical Analysis of Glutamine, Lactate, Ammonium, and
Media Age further confirms that the starting lactate level did not impact cell growth.
Ammonium production and cell growth show a distinct difference between samples that started at a higher
ammonium value and the samples that started at a lower ammonium value. The importance of the initial
ammonium value is confirmed in the linear regression. Unfortunately, the ammonium level of the old and newAmmoniu m
media are near identical so initial ammonium level does not explain the difference between the two. It is possible
that a higher starting ammonium level is prohibiting cells from Experiment 5 from reaching levels achieved in
Experiment 2.
pH follows the same trend as pH from Experiment 2 and there was no major difference between the samples in
Experiment 5.
Osmolality follows the same trend as osmolality from Experiment 2 and there was no major difference between
the samples in Experiment 5.
Glutamine Glutamine consumption is clearly tied to cell growth but it does not to be influential in encouraging cell growth.
Cell Density
The higher glutamine samples, from the new media lot, do not grow any better than the lower glutamine samples.
Glutamic acid follows a similar trend between Experiment 2 and Experiment 5 and within the samples of
Glutamic Acid
Experiment 5.
A different lot was found to simulate new media but the results opposite of what previous experiment predicted.
CDM Age The older media grew better than the newer media, and the newer media failed to reach even 100% cell density.
This implied that something other than media age is inhibiting cell growth.
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